AI-Based Covid-19 / Omicron Early Detection System
AI system for early symptom-based detection of Covid-19 and Omicron variants. Filed as Indian Patent, June 2022.
Overview
During the Omicron wave of the Covid-19 pandemic, rapid early detection was critical to containing spread. This project developed an AI-based smart system for early detection of Covid-19 and Omicron symptoms, enabling faster identification before clinical testing. Filed as an Indian Patent in June 2022.
Motivation
- PCR and rapid antigen tests require access to testing centers
- Symptom onset precedes positive test results by days — AI can flag likely cases early
- Omicron presented distinct symptom patterns compared to earlier variants, requiring updated detection logic
Approach
- Symptom profiling — structured intake of reported symptoms (fever, cough, fatigue, loss of smell/taste, body aches, etc.)
- Variant-aware classification — model distinguishes likely Covid-19, Omicron, or negative cases based on symptom combinations
- ML classifier — trained on symptom-outcome data from published clinical datasets
- Risk stratification — outputs a risk level to guide self-isolation vs. clinical referral decisions
Key Outcomes
- Early detection capability before PCR confirmation
- Omicron-specific detection logic based on variant-distinct symptom patterns
- Lightweight tool accessible without specialist hardware
IP Status
Patent Filed — Indian Patent Office, June 2022.